A. Yes – A quasi-experimental study found that chemotherapy administered in rural towns under teleoncology supervision had comparable dose intensity, side-effect rates, hospital admissions and no toxicity-related deaths versus treatment at a tertiary center, concluding it is safe when adequate resources and governance are in place [Chan et al., 2015, PMID 26561905].